Accéder au contenu
Merck

Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon.

Science (New York, N.Y.) (2014-08-12)
Andrea Reboldi, Eric V Dang, Jeffrey G McDonald, Guosheng Liang, David W Russell, Jason G Cyster
RÉSUMÉ

Type I interferon (IFN) protects against viruses, yet it also has a poorly understood suppressive influence on inflammation. Here, we report that activated mouse macrophages lacking the IFN-stimulated gene cholesterol 25-hydroxylase (Ch25h) and that are unable to produce the oxysterol 25-hydroxycholesterol (25-HC) overproduce inflammatory interleukin-1 (IL-1) family cytokines. 25-HC acts by antagonizing sterol response element-binding protein (SREBP) processing to reduce Il1b transcription and to broadly repress IL-1-activating inflammasomes. In accord with these dual actions of 25-HC, Ch25h-deficient mice exhibit increased sensitivity to septic shock, exacerbated experimental autoimmune encephalomyelitis, and a stronger ability to repress bacterial growth. These findings identify an oxysterol, 25-HC, as a critical mediator in the negative-feedback pathway of IFN signaling on IL-1 family cytokine production and inflammasome activity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
25-Hydroxycholesterol, ≥98%
Avanti
25-hydroxycholesterol, Avanti Polar Lipids